Finding new treatments for leukemia and myelodysplastic syndromes.
MD NET
This study is looking for ways to create better treatments for people with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) by figuring out how different patients respond to therapies, so they can receive more personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10937979 on NIH RePORTER |
What this research studies
This research focuses on developing and optimizing new therapeutic strategies for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). It involves a master screening protocol to evaluate patients for clinical trial eligibility and a data support structure for analyzing biomarkers related to treatment response and resistance. The study aims to identify molecular signatures and characteristics that can help predict how patients will respond to different therapies, ultimately leading to more personalized treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Not a fit: Patients with other types of cancers or hematological disorders unrelated to AML or MDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with AML and MDS.
How similar studies have performed: Previous research has shown promise in identifying biomarkers and optimizing treatment strategies for leukemia, indicating that this approach has potential for success.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Parchment, Ralph — Leidos Biomedical Research, INC.
- Study coordinator: Parchment, Ralph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.